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Objectives: As part of annual cross-sectional Streptococcus pneumoniae carriage surveys in Fiji
(2012e2015), we detected pneumococci in over 100 nasopharyngeal swabs that serotyped as ‘11F-like’
by microarray. We examined the genetic basis of this divergence in the 11F-like capsular polysaccharide
(cps) locus compared to the reference 11F cps sequence. The impact of this diversity on capsule
phenotype, and serotype results using genetic and serologic methods were determined.
Methods: Genomic DNA from representative 11F-like S. pneumoniae isolates obtained from the naso-
pharynx of Fijian children was extracted and subject to whole genome sequencing. Genetic and phylo-
genetic analyses were used to identify genetic changes in the cps locus. Capsular phenotypes were
evaluated using the Quellung reaction and latex agglutination.
Results: Compared to published 11F sequences, the wcwC and wcrL genes of the 11F-like cps locus are
phylogenetically divergent, and the gct gene contains a single nucleotide insertion within a homopolymeric
region. These changes within the DNA sequence of the 11F-like cps locus have modiﬁed the antigenic prop-
erties of the capsule, such that 11F-like isolates serotype as 11A by Quellung reaction and latex agglutination.
Conclusions: This study demonstrates the ability of molecular serotyping by microarray to identify ge-
netic variants of S. pneumoniae and highlights the potential for discrepant results between phenotypic
and genotypic serotyping methods. We propose that 11F-like isolates are not a new serotype but rather
are a novel genetic variant of serotype 11A. These ﬁndings have implications for invasive pneumococcal
disease surveillance as well as studies investigating vaccine impact. S. Manna, Clin Microbiol Infect
2018;24:428.e1e428.e7
© 2017 The Author(s). Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology
and Infectious Diseases. This is an open access article under the CC BY license (http://creativecommons.
org/licenses/by/4.0/).
Introduction
Streptococcus pneumoniae (the pneumococcus) is a leading
cause of morbidity and mortality worldwide [1]. There are over 90
pneumococcal serotypes, classiﬁed by an immunologically distinct
capsule encoded by the capsular polysaccharide (cps) biosynthesis
locus of the genome. The capsule is a major virulence factor and
the basis for the currently licensed vaccines targeted toward the
pediatric and elderly communities.
Pneumococcal colonization of the nasopharynx, most common
in children younger than ﬁve years old, is considered a precursor to
disease [2]. From the nasopharynx, pneumococci can disseminate
* Corresponding author. S. Manna, Murdoch Childrens Research Institute, Royal
Children's Hospital, 50 Flemington Road, Parkville VIC 3052, Australia.
E-mail address: sam.manna@mcri.edu.au (S. Manna).
Contents lists available at ScienceDirect
Clinical Microbiology and Infection
journal homepage: www.cl in icalmicrobiologyandinfect ion.com
http://dx.doi.org/10.1016/j.cmi.2017.06.031
1198-743X/© 2017 The Author(s). Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Diseases. This is an open access article under
the CC BY license (http://creativecommons.org/licenses/by/4.0/).
Clinical Microbiology and Infection 24 (2018) 428.e1e428.e7
to other anatomic sites to cause diseases such as pneumonia, otitis
media and meningitis [3e5]. As pneumococcal conjugate vaccines
(PCVs) reduce carriage of vaccine serotypes, they provide indirect
beneﬁts to unvaccinated individuals because nasopharyngeal car-
riage also underpins host-to-host transmission [3e6].
As a result of both their direct and indirect protective effects,
PCVs play a crucial role in reducing the burden of pneumococcal
disease [7]. However, PCV introduction provides the opportunity
for serotypes not targeted by the vaccine (non-vaccine-type
pneumococci) to occupy the ecologic niche that vaccine types leave
behind. This is referred to as serotype replacement. As a result, non-
vaccine-type pneumococci are increasingly reported in carriage
and disease after PCV introduction [8]. Serotyping is therefore
important for monitoring serotype replacement in carriage and
disease surveillance. A number of pneumococcal serotyping
methods exist, with the reference standard considered to be the
Quellung reaction [9], a serologic approach that involves mixing
pneumococci with various antisera that recognize serogroup/type-
speciﬁc capsular antigens, and visualizing the reaction under the
microscope [10]. However, this method is laborious and requires
experienced microbiologists for interpretation.
Pneumococcal serotyping can be complicated by genetic vari-
ants that exist within a speciﬁc serotype, especially when molec-
ular methods are used. For example, the identiﬁcation of genetic
cps locus variants within serotype 6B led to a new serotype (6E)
being proposed. However, subsequent work conﬁrmed the diver-
gent 6E cps locus still encodes a 6B capsule polysaccharide [11]. In
contrast, serotype 11E was originally considered a genetic variant of
11A until differences in the antigenic properties of 11E and 11A
capsules were identiﬁed, conﬁrming 11E as a new serotype. This
change in phenotype is due to nonsense mutations within the wcjE
gene [12]. More recently, nonsense mutations have been identiﬁed
in the wciG gene of serotype 35B invasive isolates. This results in
variants that can no longer be serotyped by Quellung reaction and
have been proposed as a new serotype (35D) [13,14]. Because some
variations in cps sequence lead to changes in phenotype while
others do not, it is important to have a detailed understanding of
such variants and how they can affect serotyping results.
Recently our group conducted a comprehensive study that
compared 20 pneumococcal serotyping methods focusing on sero-
type detection from clinical samples [15]. Microarray, a genomics-
based molecular approach that determines serotype based on the
cps gene content of DNA extracts, was the best-performing method.
We applied the microarray to nasopharyngeal samples from chil-
dren as part of a vaccine impact study in Fiji, where PCV10 was
introduced into the national immunization schedule in 2012.
Microarray identiﬁed 106 pneumococci as ‘11F-like,’ indicating the
cps locus in these isolates was most similar to that of serotype 11F
but with divergence detected in the cps locus. In this study, we
aimed to determine ﬁrstly the genetic basis of the sequence diver-
gence in the 11F-like cps locus of S. pneumoniae isolates fromFiji, and
secondly whether these differences translate to a change in
phenotype (capsular structure), inﬂuencing serotyping results.
Methods
Nasopharyngeal swab collection and screening for pneumococci
As part of annual cross-sectional pneumococcal carriage
surveys in Fiji, nasopharyngeal swabs were collected from study
participants according to World Health Organization guidelines
[9]. Ethical approval for this study was obtained from the Fiji
National Research ethics review committee and the University of
Melbourne Human research ethics committee, with written
informed consent obtained from all the participants or their
caregivers. Participants were from four age groups: 5- to 8-week-
old infants, 12- to 23-month-old children, 2- to 7-year-old children
and adult caregivers. Swabs were placed in 1 mL skim milk, tryp-
tone, glucose and glycerol media [16] and kept in a cool box until
transport to the Fiji Centre for Communicable Disease Control,
where theywere aliquoted and stored at80C. Samples were then
shipped to the Murdoch Childrens Research Institute on dry ice and
stored at 80C until use. DNA was extracted from 100 mL aliquots
of the nasopharyngeal swabs and screened for the presence of
pneumococcal DNA using quantitative real-time PCR (qPCR) tar-
geting the lytA gene as previously described [17].
Molecular serotyping by microarray
For samples in which lytAwas detected, a previously unthawed
aliquot of the original nasopharyngeal swab was plated on horse
blood agar containing gentamicin (5 mg/mL, to select for pneumo-
cocci) and incubated overnight at 37C with 5% CO2. Bacteria were
collected from plates containing a-hemolytic growth using 1 mL
phosphate-buffered saline. DNA was extracted from the bacterial
suspensions using the QIAcube HT with the QIAamp 96 DNA QIA-
cube HT Kit (Qiagen). Molecular serotyping by microarray was
performed as described previously [15]. Brieﬂy, the Genomic DNA
ULS Labeling Kit (Agilent Technologies) was used to label 200 ng of
DNAwith a ﬂuorescent probe (either Cy3 or Cy5) by incubating the
reactions at 85C in a thermocycler with a heated lid for 30 mi-
nutes. After puriﬁcation of labelled DNA, the samples were incu-
bated overnight at 65C rotating at 20 rpm with Senti-SPv1.5
microarray slides (BUGS Bioscience) to allow hybridization to
occur. Microarray slides were subsequently washed, scanned and
analysed using Agilent microarray scanner and feature extraction
software. Data were analysed by Senti-NET software to determine
serotype calls, which were calculated using Bayesian-based models
[18].
Bacterial isolates
S. pneumoniae 11F-like isolates used in this study (PMP1342 and
PMP1343) were puriﬁed from randomly selected nasopharyngeal
swabs found to contain an 11F-like serotype by microarray
(Supplementary Table S1). a-hemolytic colonies were isolated on
horse blood agar supplemented with gentamicin (5 mg/mL) and
conﬁrmed as S. pneumoniae using optochin sensitivity testing and
whole genome sequencing.
Whole genome sequencing
Genomic DNA was extracted from pneumococcal isolates as
described above. DNA was sequenced in 2  250 bp paired end
reads using the MiSeq platform. De novo assembly was performed
using SPAdes [19] and annotated with RAST [20].
Sequence analysis
Phylogenetic analyses were performed using the software
package MEGA 6 [21]. The cps locus gene sequences from 11F-like
isolates and other serogroup 11 strains (GenBank accession nos.
GU074952, CR931654, CR931655, CR931656, GU074953, CR931657)
were aligned using MUSCLE. Maximum likelihood trees were then
generated from the alignment using the Tamura-Nei model. Sta-
tistical support for the branches was ascertained by bootstrapping
(1000 replicates). For the identiﬁcation of single residue sub-
stitutions, insertions or deletions, 11F-like cps sequences were
aligned to known 11A and 11F sequences using Clustal Omega. The
11F-like cps sequences have been deposited in GenBank (accession
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nos. MF140334 and MF140335 for PMP1342 and PMP1343
respectively).
Quellung serotyping
Quellung serotyping was performed as described previously
[10] using antisera from the Statens Serum Institut (SSI) (http://
www.ssi.dk/ssidiagnostica). Brieﬂy, pneumococcal growth from
an overnight pure culture was collected from an agar plate to make
a slightly turbid saline suspension. Using an inoculation loop, 1 mL
was placed on a microscope slide and mixed with 1 mL of antisera.
The sample was then viewed under the microscope (400
magniﬁcation) for cells with an enlarged or swollen appearance,
indicative of a positive reaction.
Serotyping by latex agglutination
Serotyping by latex agglutination was performed with latex
reagents prepared using SSI antisera and adapted from a previously
described method [22]. A saline suspension of the pneumococcal
culture was prepared to a density equivalent to a 4 or 5 McFarland
standard. Using a glass slide, 10 mL of the bacterial suspension was
mixed with 10 mL of the latex reagent containing the SSI antisera of
interest. The slide was then incubated on an orbital shaker for
2 minutes at ~140 rpm before observing the reactions for
agglutination.
Results
As part of a pneumococcal carriage survey in Fiji, we have
conducted serotyping by DNA microarray on 2455 pneumococcal
cultures derived from aliquots of nasopharyngeal swabs obtained
between 2012 and 2015. Of these, 106 (4.3%) contained pneumo-
cocci that typed as 11F-like by microarray, which detects all 16
genes from the 11F cps locus (wzg, wzh, wzd, wze, wchA, wchJ, wchK,
wcyK, wcwC, wcrL, wzy, wcwT, wcwU, wzx, gct, wcjE). This was based
on similarity to serotype 11F cps gene content but with divergence
in the wcwC and wcrL genes. 11F-like pneumococci were found in
participants sampled both before and after PCV10 introduction, and
across all age groups tested (19/517, 3.7%, in 5- to 8-week-olds,
28/847, 3.3%, in 12- to 23-month-olds and 52/897, 5.8%, in 2- to
7-year-olds, as well as 7/194, 3.6%, in adult caregivers). 11F-like was
the most predominant member from serogroup 11, with only a
small number of isolates identiﬁed as 11A by microarray (5/2455,
0.2%) and with 11B, 11C, 11D and 11F not detected.
To investigate and conﬁrm the genetic basis underlying the
divergence in the S. pneumoniae 11F-like cps sequences, the ge-
nomes of representative 11F-like isolates, PMP1342 and PMP1343
(Supplementary Table S1), were sequenced. Pairwise sequence
alignments comparing 11F and 11F-like serogroup 11especiﬁc
genes conﬁrmed that most genes were highly homologous
(96e99% identical at the DNA level) (Supplementary Table S2). Two
11F-like cps genes, wcwC and wcrL, exhibited less similarity (81.8%
and 84.4% respectively) (Supplementary Table S2), supporting the
microarray results that indicated these genes as the source of the
genetic divergence from the 11F cps locus. To validate these ﬁnd-
ings, phylogenetic analyses were performed comparing serogroup
11especiﬁc cps genes of 11F-like isolates with cps gene sequences
from other serotypes in serogroup 11 (11F, 11A, 11B, 11C, 11D, 11E).
Only serogroup 11 sequences were used in this analysis. In the case
of wcrL, this is because this gene is unique to serogroup 11.
Although wcwC is present in noneserogroup 11 serotypes (7F, 7A,
22F, 22A), their level of DNA sequence identity to the 11F-like
wcwC was signiﬁcantly lower (the highest identity score to a
noneserogroup 11 sequence was 60.6%, compared to over 81% with
sequences from serogroup 11 serotypes). In addition, the micro-
array did not detect any similarity to other cps genes from other
serotypes. The majority of serogroup 11especiﬁc 11F-like cps genes
were most closely related to the canonical 11F locus (Fig. 1) except
wcwC (Fig. 1(E)) and wcrL (Fig. 1(F)), which did not cluster with any
serogroup 11 sequences. The genetic divergence of wcwC and wcrL
was also evident using a Bayesian model to infer phylogeny
(Supplementary Fig. S1). This supports the serotype call made by
microarray and identiﬁes wcwC and wcrL as the divergent genes
yielding the 11F-like result.
The wcrL gene encodes a glycosyltransferase involved in the
transfer of the fourth sugar residue (either a-N-acetylglucosamine
(aGlcNAc) or glucose (aGlc)) to the capsular polysaccharide repeat
unit [23]. Supporting the phylogenetic analysis, in silico translation
of 11F-like wcrL sequence revealed signiﬁcant sequence diversity
from the 11F WcrL polypeptide sequence (82% identity) (Fig. 2). It is
plausible that this divergence could affect the transferase activity of
WcrL and therefore the antigenic properties of the 11F-like capsule.
To determine this, we performed Quellung serotyping. The 11b
factor serum reactswith serogroup 11 capsules that contain aGlcNAc
(11F, 11B, 11C, 11D) [24]. No Quellung reaction was observed when
11F-like isolates were mixed with the 11b factor serum (Table 1).
Serogroup 11 capsules have one of two phosphopolyalchohol
pendants, glycerol-1-phosphate (Gro1P) or ribitol phosphate (Rib-
ol). In the serogroup 11 cps locus, gct encodes a CDP-glycerol syn-
thetase, which catalyzes the biosynthesis of Gro1P. Serotype 11F
and 11B capsules lack Gro1P as a result of a single nucleotide
deletion in gct that results in a frameshift [25]. Although phyloge-
netic analyses of 11F-like gct sequences weremost closely related to
the 11F and 11B gct sequences (Fig. 1(K)), the open reading frame of
the 11F-like gct sequence is intact (i.e. with an additional nucleotide
present) (Fig. 3). An intact gct open reading frame suggests Gro1P
would be present in the 11F-like capsule. This predicted change in
phenotype was validated by Quellung reaction using factor sera 11c
and 11g, which recognize Gro1P (11A,11C,11D) and Rib-ol (11F,11B)
respectively [24]. The 11F-like capsule reacted with 11c but not 11g,
thus conﬁrming the presence of a Gro1P phosphopolyalchohol
pendant (Table 1).
Upon testing the 11F-like isolates with all serogroup 11 factor
sera, it was evident that 11F-like isolates serotype as 11A by Quel-
lung reaction (Table 1). This ﬁnding was conﬁrmed by conducting
latex agglutination serotyping (which uses the same factor sera as
Quellung reaction) on six additional 11F-like isolates, all of which
typed as 11A (Supplementary Table S3). Representative results of
these agglutination reactions are shown in Fig. 4. Therefore,
although they contain a cps locus most closely related to serotype
11F,minor genetic changes in this locushave resulted in the abilityof
11F-like isolates to synthesize a capsular polysaccharide resembling
that of serotype 11A based on cross-reaction with typing antisera.
Discussion
In this study, we identiﬁed and characterized a new pneumo-
coccal serotype variant from a vaccine impact study in Fiji. Geno-
typic serotyping of these isolates by microarray identiﬁed a cps
locus that is closely related to the 11F cps locus but genetically
divergent as a result of sequence variation within the wcwC and
wcrL genes. Quellung reaction and latex serotyping revealed that
the 11F-like capsule phenotypically serotypes as 11A (Fig. 4 and
Table 1).
11F-like capsules lack aGlcNAc and contain Gro1P, demon-
strating that the genetic differences between 11F and 11F-like cps
loci yield capsules with differing antigenic properties.
The substrate afﬁnity and glycosyltransferase activity of WcrL
varies among serotypes within serogroup 11 and is determined by
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the amino acid at position 112. WcrL enzymes with alanine at this
position transfer aGlcNAc (11F, 11B, 11C), those with asparagine
transfer aGlc (11A), and those with serine transfer both (11D) [23].
In contrast to the 11F WcrL, the 11F-like WcrL possesses an aspar-
agine at this position (Fig. 2). This explains why no Quellung or
latex agglutination reaction occurred with the 11b factor sera
(which detects aGlcNAc) (Table 1 and Fig. 4), as the 11F-like WcrL
would not be able to transfer aGlcNAc, resulting in the 11F-like
capsule lacking this modiﬁcation.
The CDP-glycerol synthetase encoded by gct catalyzes the syn-
thesis of Gro1P, which is subsequently incorporated into the
capsule repeat unit byWcwU. In serotypes 11B and 11F, gct does not
encode a functional enzyme as a result of a single nucleotide
deletion, explaining the absence of Gro1P in their capsules. While
this has been reported previously [25], the site of the deletion has
not been described; nor has the mechanism by which it may have
occurred been postulated. We identiﬁed that the deletion is located
within a homopolymeric region of seven tandemly repeated
adenosine nucleotides (Fig. 3). Sequences such as this can be un-
stable and subject to slipped-strand mispairing during DNA repli-
cation, resulting in the insertion or deletion of a single nucleotide.
Such spontaneous frameshift mutations have been reported
Fig. 1. Phylogenetic analysis of serogroup 11 capsular polysaccharide genes from 11F-like isolates (PMP1342 and PMP1343) with serogroup 11 strains MNZ272 (11A), 8087/40 (11B),
Eddy no. 53 (11C), 70/86 (11D), MNZ264 (11E) and 34356 (11F), (GenBank accession nos. GU074952, CR931654, CR931655, CR931656, GU074953, CR931657 respectively). Genes
speciﬁc to serogroup 11 include; wchA (A), wchJ (B), wchK (C), wcyK (D), wcwC (E), wcrL (F), wzy (G), wcwT (H), wcwU (I), wzx (J), gct (K) and wcjE (L). Trees for wcwC and wcjE do not
include sequences from 11B and 11C as these serotypes lack these genes. Using MEGA 6 package [21], DNA sequences were aligned using MUSCLE; and maximum likelihood of
phylogeny trees were generated based on Tamura-Nei model. Scale bars represent number of substitutions per site. Statistical support for branches was determined by boot-
strapping (1000 replicates) and are displayed as percentages.
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previously, including within homopolymeric adenosine repeat re-
gions of pneumococcal virulence genes pspA and spxB [26]. In
serogroup 15, slipped-strandmispairing of a TA dinucleotide repeat
in the wciZ gene is the basis for the structural differences between
15B and 15C capsules [27]. Thus, we propose that the single
nucleotide deletion in the gct gene of 11F and 11B is the result of a
slipped-strand mispairing event and explains the difference in the
phosphopolyalchohol pendant of the capsule of these serotypes
with 11A, 11C and 11D.
In the case of the 11F-like gct gene, our phylogenetic analysis
identiﬁed it is closely related to the 11F and 11B gct genes (Fig.1(K)).
In comparison to the 11F and 11B sequences, the 11F-like gct gene
contains a single nucleotide insertion in the homopolymeric region
(Fig. 3). We hypothesize that this insertion occurred by slipped-
strand mispairing and restored the open reading frame, allowing
Gro1P synthesis and its subsequent incorporation into the capsule,
explaining why these isolates react with 11c factor sera (which
detects Gro1P) (Table 1 and Fig. 4). Alternatively, it is possible that
11F-like is a closely related progenitor of 11F in which the slipped-
strand mispairing event has not yet occurred. Interestingly, gct
homologues are present in the cps locus of serogroups 16 and 18,
and serotype 45, which also possess similar homopolymeric re-
gions and may therefore also be subject to slipped-strand
mispairing.
Our genetic analyses also identiﬁed the acetyltransferase gene
wcwC as a source of divergence in the 11F-like sequence (Fig. 1(E)
and Supplementary Fig. S2). WcwC is responsible for O-acetylation
of galactose in the capsular polysaccharide subunit [24]. Interest-
ingly, genetic variants that emergewithin other serotypes that have
phenotypic consequences have been attributed to nonsense
mutations in acetyltransferase genes [12e14,27]. However, the
11F-like wcwC gene still contains an intact open reading frame.
It remains to be elucidated whether divergence in the wcwC
sequence translates to changes in acetylation patterns in the
11F-like capsule.
The microarray platform uses a high level of stringency for the
detection of cps genes because a high level of identity (above 90%) is
required to conclude that a particular cps gene from a speciﬁc
serotype is present. In the case of the isolates described in this
study, they were designated with the ‘like’ annotation because the
divergence inwcwC andwcrL (Fig. 1(E) and (F)) meant that they did
not meet the sequence identity criteria to be called 11F. Microarray
can discriminate between serotypes 11A and 11F because of the
wchJ and wchK genes, which are highly divergent between these
serotypes. The 11F-like wchJ and wchK genes were more similar to
the 11F homologues compared to 11A (Fig. 1(B) and (C) and
Supplementary Table S2), which is why the microarray called the
variants identiﬁed in our study 11F-like and not 11A-like.
As we progress through the genomics era, the beneﬁts provided
by genetic approaches such as microarray to infer pneumococcal
serotype are making these methods an attractive alternative to the
more laborious phenotypic methods. However, as demonstrated in
our study, it is important to note that this will not always be
reﬂective of serotype, especially with the existence of genetic var-
iants that are yet to be discovered. Given that multiple genetic
approaches to pneumococcal serotyping are commonly utilized, it
is important to consider how such methods (in addition to micro-
array and DNA sequencing) would report the 11F-like variant,
which genetically resembles 11F across most of the cps locus. The
US Centers for Disease Control and Prevention recommend a qPCR-
Fig. 2. Alignment of 11F-like WcrL amino acid sequence with 11A and 11F sequences generated by Clustal Omega. Identical residues are indicated with an asterisk; conserved
residents, a colon; and semiconserved residues by a period respectively. Highlighted is residue 112 (A, alanine; N, asparagine).
Table 1
Phenotypic serotyping for 11F-like isolates and Statens Serum Institut (SSI) reference strains (11F, 11A, 11B, 11C and 11D)
Factor serum Major capsular antigen detected [23] 11F 11A 11B 11C 11D PMP1342 (11F-like) PMP1343 (11F-like)
11b aGlcNAc þ  þ þ þ  
11c Glycerol-1-phosphate (Gro1P)  þ  þ þ þ þ
11f O-acetylation of a-Gal-H2   þ þ   
11g Ribitol phosphate (Rib-ol) þ  þ    
Serotyping was performed using Quellung reaction as previously described [10], with ‘þ’ and ‘’ indicating a positive and negative reaction respectively with factor sera from
SSI (http://www.ssi.dk/ssidiagnostica).
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based approach using primers and a probe for 11A/11D that target
the wzy gene of the cps locus [28]. When we performed this qPCR,
both the 11A SSI reference strain and our 11F-like isolates were
detected (Supplementary Table S4). In addition, these primers and
probe also detected the 11F SSI reference strain (Supplementary
Table S4), suggesting this qPCR method cannot distinguish be-
tween 11A, 11D, 11F and 11F-like. To our knowledge, this qPCR
system has not previously been validated against serotype 11F. The
11F and 11F-likewzy sequences contain very fewmismatches in the
annealing sites of these primers and probe (Supplementary Fig. S3).
Therefore, it is not surprising that this qPCR would also detect
serotype 11F.
Another qPCR method, described by Sakai et al. [29], uses
primers and probe targeting the 11F wchK gene, which does not
detect 11A. This 11F-speciﬁc qPCR also detected the 11F-like iso-
lates (consistent with the observation that the 11F-like wchK gene
was most closely related to the 11F sequence, Fig. 1(C)), leading to a
mistyping of these variants (Supplementary Table S4). Kapatai et al.
[30] described a bioinformatic tool (PneumoCaT) that can be used
to infer serotype fromwhole genome sequence data. In the case of
serogroup 11, the pipeline is designed such that it can detect the
small genetic differences between serotypes such as gct allele (in
frame or frameshifted) and the codon starting at position 334 in
wcrL (that speciﬁes the amino acid at position 112). As a result,
when the sequence reads of the 11F-like isolates were run through
the PneumoCaT pipeline, they were correctly typed as 11A (score 5/
5; presence of wcwC and wcjE, absence of wcwR, intact gct ORF and
wcrL codon starting at position 334 as AAU, which speciﬁes N at
amino acid position 112). Overall, it is evident that most genetic
approaches to pneumococcal serotyping would mistype the vari-
ants described in our study as 11F unless they take into account
Fig. 3. Alignment of 11F-like gct DNA sequences with 11A and 11F sequences generated using Clustal Omega. Identical residues are indicated with an asterisk. Box represents
homopolymeric region with mutation site.
Fig. 4. Representative latex agglutination reactions of Statens Serum Institut (SSI) 11F
and 11A reference strains, and an 11F-like isolate from this study. Latex reagents were
prepared using SSI antisera (11b, 11c, 11f, 11g) as Quellung as previously described [22].
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relevant small variations. Therefore, although genetic approaches
to serotyping are advantageous, it is important that they do not
completely replace phenotypic methods. Serologic methods pro-
vide insights into the antigenic properties of capsules produced by
different serotypesdimportant knowledge to be taken into
consideration for vaccine formulation.
Our study highlights the use of microarray for identiﬁcation of
genetic variants of S. pneumoniae in clinical samples. The data from
this study will be used to update microarray slides to accurately
identify 11F-like variants in future studies to accurately measure
prevalence. Of interest, we have identiﬁed nasopharyngeal isolates
from Lao PDR and Mongolia that also typed as 11F-like by micro-
array, suggesting that this variant may be widespread. We have
identiﬁed that serotyping calls for serogroup 11 from molecular
approaches can differ from those using phenotypic methods. This
has implications for pneumococcal disease surveillance and
monitoring serotype replacement after vaccine introduction. Ulti-
mately, a combination of genotypic and phenotypic pneumococcal
serotyping methods may be needed at reference centers to detect
pneumococcal serotype variants and fully characterize the effect of
vaccination on pneumococcal epidemiology.
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